Aprea Therapeutics, Inc.: cashflow_operating
| Value | {"amount": -19273989, "concept": "us-gaap:NetCashProvidedByUsedInOperatingActivities", "currency": "USD"} |
|---|---|
| Period | 2021-01-01 – 2021-06-30 |
| Status | superseded |
| Entity | Aprea Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:02:22.995812+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/3e50d4ba-d965-44e0-bf45-d7007b696781
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001558370-21-011504Retrieved: 2026-08-19T18:02:22.995812+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001781983/cashflow-operating/2021-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/3e50d4ba-d965-44e0-bf45-d7007b696781
History
- no predecessors — first report